Integrating Deep Learning and Radiomics in Differentiating Papillary Thyroid Microcarcinoma from Papillary Thyroid Carcinoma with Ultrasound Images

结合深度学习和放射组学,利用超声图像鉴别乳头状甲状腺微癌和乳头状甲状腺癌

阅读:1

Abstract

PURPOSE: The feasibility and accuracy of ultrasound-based radiomics, deep learning, and combined deep learning radiomics models were investigated in the differentiation of papillary thyroid carcinoma and papillary thyroid microcarcinoma to decrease the risk of overtreatment of papillary thyroid microcarcinoma. METHODS: A total of 549 patients with confirmed 180 papillary thyroid carcinoma and 436 papillary thyroid microcarcinoma nodules from Hospital One were enrolled and randomly divided into training and validation cohorts at a ratio of 8:2 with 56 patients left as independent testing set 1. Fifty patients from Hospital Two were enrolled as independent testing set 2. Radiomics signature and five deep learning networks, such as visual geometry group 13 (VGG13), VGG16, VGG19, AlexNet, and EfficientNet, were generated for papillary thyroid carcinoma and papillary thyroid microcarcinoma differentiation. Combined deep learning and radiomics models were constructed to further improve the differentiation ability. RESULTS: An area under curves of 0.826 and 0.822 was achieved with radiomics model for papillary thyroid carcinoma and papillary thyroid microcarcinoma differentiation in the independent testing set 1 and set 2, respectively. VGG19 achieved the best area under curves of 0.890 and EfficientNet achieved the best accuracy of 0.867. The best accuracy and area under curves of 0.904, 0.900, and 0.931, 0.946 were achieved with the combination of VGG + radiomics (R_V_Combined) and EffiecientNet + radiomics (R_E_Combined) in the independent testing set 1 and set 2, respectively. CONCLUSION: Deep learning and radiomics combination models are promising in the noninvasively preoperative differentiation of papillary thyroid microcarcinoma and papillary thyroid carcinoma to decrease the overtreatment of patients with papillary thyroid microcarcinoma and to minimize the complications caused by overtreatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。